Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, September 28, 2022
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
[ Wed, Sep 28th 2022
] - WOPRAI
Constantine Davides Maintained (BIVI) at Strong Buy with Decreased Target to $80 on, Sep 28th, 2022
Constantine Davides of EF Hutton, Maintained "BioVie Inc." (BIVI) at Strong Buy with Decreased Target from $140 to $80 on, Sep 28th, 2022.
Constantine has made no other calls on BIVI in the last 4 months.
There is 1 other peer that has a rating on BIVI. Out of the 1 peers that are also analyzing BIVI, 0 agree with Constantine's Rating of Hold.
This is the rating of the analyst that currently disagrees with Constantine
- Charles Duncan of "Cantor Fitzgerald" Initiated at Buy and Held Target at $70 on, Friday, July 22nd, 2022
